Universal Health Services Valuation
Is UHS * undervalued compared to its fair value, analyst forecasts and its price relative to the market?
Valuation Score
2/6Valuation Score 2/6
Below Fair Value
Significantly Below Fair Value
Price-To-Earnings vs Peers
Price-To-Earnings vs Industry
Price-To-Earnings vs Fair Ratio
Analyst Forecast
Share Price vs Fair Value
What is the Fair Price of UHS * when looking at its future cash flows? For this estimate we use a Discounted Cash Flow model.
Below Fair Value: UHS * (MX$2904.5) is trading above our estimate of fair value (MX$2584.55)
Significantly Below Fair Value: UHS * is trading above our estimate of fair value.
Key Valuation Metric
Which metric is best to use when looking at relative valuation for UHS *?
Other financial metrics that can be useful for relative valuation.
What is UHS *'s n/a Ratio? | |
---|---|
n/a | 0x |
n/a | n/a |
Market Cap | US$9.56b |
Key Statistics | |
---|---|
Enterprise Value/Revenue | 1.1x |
Enterprise Value/EBITDA | 8.8x |
PEG Ratio | 1.5x |
Price to Earnings Ratio vs Peers
How does UHS *'s PE Ratio compare to its peers?
Company | Forward PE | Estimated Growth | Market Cap |
---|---|---|---|
Peer Average | 47.5x | ||
MEDICA B Médica Sur. de | 7.9x | 5.6% | Mex$4.3b |
EHC Encompass Health | 22.7x | 8.9% | US$8.7b |
RHC Ramsay Health Care | 52.7x | 17.3% | AU$11.6b |
APOLLOHOSP Apollo Hospitals Enterprise | 106.5x | 35.5% | ₹841.0b |
UHS * Universal Health Services | 14x | 8.1% | Mex$9.6b |
Price-To-Earnings vs Peers: UHS * is good value based on its Price-To-Earnings Ratio (14x) compared to the peer average (23.2x).
Price to Earnings Ratio vs Industry
How does UHS *'s PE Ratio compare vs other companies in the Global Healthcare Industry?
Price-To-Earnings vs Industry: UHS * is good value based on its Price-To-Earnings Ratio (14x) compared to the Global Healthcare industry average (22.8x).
Price to Earnings Ratio vs Fair Ratio
What is UHS *'s PE Ratio compared to its Fair PE Ratio? This is the expected PE Ratio taking into account the company's forecast earnings growth, profit margins and other risk factors.
Fair Ratio | |
---|---|
Current PE Ratio | 14x |
Fair PE Ratio | n/a |
Price-To-Earnings vs Fair Ratio: Insufficient data to calculate UHS *'s Price-To-Earnings Fair Ratio for valuation analysis.
Analyst Price Targets
What is the analyst 12-month forecast and do we have any statistical confidence in the consensus price target?
Analyst Forecast: Insufficient data to show price forecast.